Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 4.887\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1ccc(C(=O)CSc2ncnc3ccccc23)o1
b. C#CCOc1c(Br)cc(/C=N\NC(=O)CN2CCOCC2)cc1OCC
c. CCCc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(O)cc1
Answer: b. C#CCOc1c(Br)cc(/C=N\NC(=O)CN2CCOCC2)cc1OCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCOc1c(Br)cc(/C=N\NC(=O)CN2CCOCC2)cc1OCC
C#CCOc1c(Br)cc(/C=N\NC(=O)CN2CCOCC2)cc1OCC
N-[(Z)-(3-bromo-5-ethoxy-4-prop-2-ynoxyphenyl)methylideneamino]-2-morpholin-4-ylacetamide